{
    "root": "30168ea9-9be5-75bd-e063-6394a90ab409",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Famotidine",
    "value": "20250311",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FAMOTIDINE",
            "code": "5QZO15J2Z8"
        }
    ],
    "indications": "Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of:\n                  • active duodenal ulcer (DU).\n                  • active gastric ulcer (GU).\n                  • symptomatic nonerosive gastroesophageal reflux disease (GERD).\n                  • erosive esophagitis due to GERD, diagnosed by biopsy. \n                  Famotidine tablets are indicated in adults for the:\n                  • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).\n                  • reduction of the risk of duodenal ulcer recurrence.",
    "contraindications": "Indication Recommended Dosage ( 2.1 ) Adult and Pediatric Patients 40 kg and greater Active DU 40 mg once daily; or 20 mg twice daily Active GastricUlcer 40 mg once daily GERD 20 mg twice daily Erosive Esophagitis 20 mg twice daily; or40 mg twice daily Adults Pathological Hypersecretory Conditions 20 mg every 6 hours; adjust to patient needs; maximum 160 mg every 6 hours Risk Reduction of DU Recurrence 20 mg once daily • See full prescribing information for complete dosing information, including dosing in renal impairment, and recommended treatment duration. ( 2.1 , 2.2 ) Administration ( 2.3 ): Take once daily before bedtime or twice daily in the morning and before bedtime with or without food.",
    "warningsAndPrecautions": "Famotidine tablets USP, 20 mg are yellow, film-coated, round shaped tablets with ‘C’\n                  119\n                  on one side and plain on other side and are supplied in bottles of 60's counts - NDC 68645-594-59.\n                  \n                  \n                     Storage\n                  \n                  Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].\n                  Dispense in a USP tight, light-resistant container.",
    "adverseReactions": "Famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (H\n       \n \n  2) receptor antagonists."
}